Omicron as severe as previous COVID variants, large U.S.study finds |
mike kraft |
Group Post |
05/05/22 |
Omicron BA.2 subvariant will soon dominate in U.S., but Fauci doesn’t expect another surge |
mike kraft |
Group Post |
03/24/22 |
Omicron BA.2 Variant May Be Extra Transmissible |
mike kraft |
Group Post |
01/25/22 |
Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds |
mike kraft |
Group Post |
12/07/22 |
Omicron BQ Covid variants, which threaten people with compromised immune systems, are now dominant in U.S. |
mike kraft |
Group Post |
11/28/22 |
Omicron BQ, XBB subvariants evade boosters and antibody treatments -- study |
mike kraft |
Group Post |
12/15/22 |
Omicron brings COVID-19 vaccine inequity ‘home to roost’ |
mike kraft |
Group Post |
11/29/21 |
Omicron can evade vaccines, but Pfizer says booster jabs do the trick |
Naomisfreeman |
Group Post |
12/08/21 |
Omicron cannot escape T cells; boosters protect households from Omicron --research summaries |
mike kraft |
Group Post |
12/30/21 |
Omicron COVID booster cuts hospitalization in over 65s -- Israeli study |
mike kraft |
Group Post |
01/09/23 |
Omicron COVID variant 75% less likely to kill than Delta strain --South Korea study |
mike kraft |
Group Post |
02/22/22 |
Omicron drives Covid surges, U.S. cases rising again. |
mike kraft |
Group Post |
11/25/22 |
Omicron evades immunity better than Delta-- Danish study |
mike kraft |
Group Post |
01/03/22 |
Omicron Hospitalization Doubled in Unvaxxed Children--CDC |
mike kraft |
Group Post |
04/20/22 |
Omicron infections contagious for at least 6 days; Takeda drug shows promise as COVID treatment --research |
mike kraft |
Group Post |
03/07/22 |
Omicron Infections Seem to Be Milder, Three Research Teams Report, but more contageous |
mike kraft |
Group Post |
12/23/21 |
Omicron is latest blow to pandemic-weary front-line workers; clashes over alternative treatments |
mike kraft |
Group Post |
12/24/21 |
Omicron is starting to eat into Delta’s U.S. dominance --CDC data |
mike kraft |
Group Post |
12/16/21 |
Omicron keeps finding new evolutionary tricks to outsmart our immunity |
mike kraft |
Group Post |
10/25/22 |
Omicron less likely than wild-type virus to result in long COVID--Swiss study suggests |
mike kraft |
Group Post |
03/10/23 |
Omicron Less Likely to Cause Long COVID, Data Suggest |
FNUOvviyaa |
Group Post |
06/17/22 |
Omicron may be headed for a rapid drop in US and Britain--projections |
mike kraft |
Group Post |
01/11/22 |
Omicron may be headed for in Britain, US; cases plateau in Africa |
mike kraft |
Group Post |
01/13/22 |
Omicron may cause milder symptoms. But experts aren’t breathing easy yet. |
mike kraft |
Group Post |
11/30/21 |
Omicron more likely to reinfect than Delta and is no milder - UK study |
mike kraft |
Group Post |
12/17/21 |
Omicron now dominant strain of coronavirus in the U.S, 73% of new cases |
mike kraft |
Group Post |
12/20/21 |
Omicron offshoot XBB.1.5 could drive new Covid-19 surge in US |
mike kraft |
Group Post |
01/03/23 |
Omicron overview: Biden tightens travel rules amid new Omicron cases |
mike kraft |
Group Post |
12/03/21 |
Omicron relatives -- BA.4 and BA.5-- are behind a fresh wave of COVID-19 in South Africa, and could be signs of a more predictable future for SARS-CoV-2. |
mike kraft |
Group Post |
05/09/22 |
Omicron reported in 57 countries, hospitalisations set to rise--WHO |
mike kraft |
Group Post |
12/08/21 |
Omicron spreading rapidly in U.S. and could bring punishing wave as soon as January, CDC warns |
mike kraft |
Group Post |
12/15/21 |
Omicron spreading so fast it threatens Britain’s hospitals |
mike kraft |
Group Post |
12/14/21 |
Omicron still dominant variant globally as XBB.1.5 gains ground, but overall declines noted --WHO |
mike kraft |
Group Post |
02/09/23 |
Omicron sub-lineage variant under investigation by U.K. |
mike kraft |
Group Post |
01/21/22 |
Omicron sub-variant BA.2 makes up 11.6% of COVID variants in U.S. - CDC |
mike kraft |
Group Post |
03/08/22 |
Omicron sub-variant now up to 23.1% of COVID variants in U.S. - CDC |
mike kraft |
Group Post |
03/15/22 |
Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases - CDC |
mike kraft |
Group Post |
01/27/23 |
Omicron subvaniants BA.4 and BA.5 have become dominant in the U.S.--CDC |
mike kraft |
Group Post |
06/29/22 |
Omicron subvariant BA.2 is rising. What do we know about it |
mike kraft |
Group Post |
02/10/22 |
Omicron subvariant XBB.1.5 accounts for 43% of U.S. COVID cases - CDC |
mike kraft |
Group Post |
01/13/23 |
Omicron subvariant XBB.1.5 now makes up nearly half of U.S. COVID cases- CDC |
mike kraft |
Group Post |
01/23/23 |
Omicron subvariants EG.5 and XBB.2.3 are making inroads in the U.S. |
mike kraft |
Group Post |
07/10/23 |
Omicron subvariants evolve rapidly, posing new threats, even to vaccinated |
mike kraft |
Group Post |
10/20/22 |
Omicron subvariants pose a new threat to people with immune deficiencies |
mike kraft |
Group Post |
10/24/22 |
Omicron subvariants that are more infectiousness are causing more than 70% of U.S. infections |
mike kraft |
Group Post |
12/09/22 |
Omicron survives longer on plastic, skin than prior variants; nose swabbing found best for rapid tests --studies |
mike kraft |
Group Post |
01/25/22 |
Omicron survives longer on some surfaces, studies find; but it's no reason to panic |
mike kraft |
Group Post |
03/18/22 |
Omicron symptoms mild so far, says South African doctor who spotted it |
mike kraft |
Group Post |
11/29/21 |
Omicron symptoms: What we know about the illness caused by the new subvariants |
mike kraft |
Group Post |
07/08/22 |
Omicron v. delta: Battle of coronavirus mutants is critical to future of pandemic |
mike kraft |
Group Post |
12/07/21 |
Recent Comments